Drug intelligence / Profile preview

NTP

Development stage
Unknown
Modality
Alpha Emitters → Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Beta Emitters → Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Small Molecules
Administration
Topical, Intraarterial, Intravenous
01

Overview

NTP is a highly non-specific abbreviation that refers to several distinct entities, some of which are pharmaceutical drugs or drug-related. In clinical contexts, "NTP" can refer to Nitroglycerin or Sodium Nitroprusside, both of which are vasodilators. Nitroglycerin is used topically or intraarterially to prevent radial artery occlusion, while Sodium Nitroprusside is administered intravenously for conditions like right heart failure. "NTP" also designates 99mTc-NTP 15-5, a radiopharmaceutical tracer used for imaging cartilage in conditions like osteoarthritis and breast cancer. Furthermore, "NTP" stands for nucleoside triphosphate, a class of biochemical molecules that serve as building blocks for RNA. Modified nucleoside triphosphates, such as arabinose nucleotides (ara-NTP), have been investigated as antiviral agents, inhibiting viral polymerases by inducing prolonged pauses during RNA elongation. Other uses of "NTP" in the provided context include Non-thermal plasma (a physical treatment modality), Neuromuscular Training Programs (behavioral interventions), and as part of diagnostic test names or organizational acronyms, which are not considered drugs.

02

Targets

RdRp (Coronavirus RNA-dependent RNA polymerase)NOS1 (nNOS)FMOD (Fibromodulin / FMOD)

Beyond the preview

Go deeper on NTP.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NTP.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call